| CAS NO: | 1553977-17-5 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Ibrutinib D5 is the penta-deuterated form (in the terminal phenyl ring) of Ibrutinib (PCI-32765; Imbruvica), which is an approved anticancer drug acting as a covalent/irreversible and orally bioavailable Brutons tyrosine kinase (Btk) inhibitor with potential anti-cancer activity.
纯度：≥98%
CAS：1553977-17-5
m.cnreagent.com